Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (381-390 of 531) with videos related to

Pageof 54
Sort By:
Pharmacotherapy|March 28, 2009
Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapyErika J Ernst, Michael E Klepser, John A Bosso, et al.
Materials (Basel, Switzerland)|July 25, 2018
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSAKetki Bhise, Samaresh Sau, Razieh Kebriaei, et al.
Infectious Diseases and Therapy|October 23, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's ComplicatedJessica K Ortwine, Evan J Zasowski, Jason M Pogue, et al.
Cancer Research|February 15, 1997
Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assayM Yoshida, R J Rybak, Y Choi, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolatesCallan R Bleick, Sean R Van Helden, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infectionsR J Rybak, C B Hartline, Y L Qiu, et al.
Antiviral Chemistry & Chemotherapy|July 5, 2001
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infectionsK Y Hostetler, R J Rybak, J R Beadle, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus BacteremiaGeorge Sakoulas, Joshua Olson, Juwon Yim, et al.
Pharmacotherapy|September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelinesRavina Kullar, Steven N Leonard, Susan L Davis, et al.
The Journal of Emergency Medicine|January 22, 2015
Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospitalCharles V Pollack, Alpesh Amin, William T Ford, et al.
Pageof 54

Showing results (381-390 of 531) with videos related to

Sort By:
Pageof 54
Pharmacotherapy|March 28, 2009
Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapyErika J Ernst, Michael E Klepser, John A Bosso, et al.
Materials (Basel, Switzerland)|July 25, 2018
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSAKetki Bhise, Samaresh Sau, Razieh Kebriaei, et al.
Infectious Diseases and Therapy|October 23, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's ComplicatedJessica K Ortwine, Evan J Zasowski, Jason M Pogue, et al.
Cancer Research|February 15, 1997
Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assayM Yoshida, R J Rybak, Y Choi, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolatesCallan R Bleick, Sean R Van Helden, Andrew D Berti, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infectionsR J Rybak, C B Hartline, Y L Qiu, et al.
Antiviral Chemistry & Chemotherapy|July 5, 2001
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infectionsK Y Hostetler, R J Rybak, J R Beadle, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus BacteremiaGeorge Sakoulas, Joshua Olson, Juwon Yim, et al.
Pharmacotherapy|September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelinesRavina Kullar, Steven N Leonard, Susan L Davis, et al.
The Journal of Emergency Medicine|January 22, 2015
Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospitalCharles V Pollack, Alpesh Amin, William T Ford, et al.
Pageof 54